RT @AnilMakam: I honestly didn't know. Seen fewer than 5 acute hep B in my career. Based on my understanding that 95% clear spontaneously &…
I honestly didn't know. Seen fewer than 5 acute hep B in my career. Based on my understanding that 95% clear spontaneously & my brief review of consensus recs, I didn't treat This @cochranecollab review suggests no better if not worse if treat https
Además del avance en diagnóstico diferencial (con el resto de serologías infecciosas), se amplió el estudio con los siguientes ensayos, además de con la carga viral 🧬: ~150.000Ul/mL. Pte d/coinfección VHD. ID: Hepatitis aguda por VHB Beneficio del 💊? htt
Here's the link to a 2017 @cochranecollab @CochraneLibrary review on the management of Hep B #NoonConference #meded https://t.co/9GjH83qZyw
Open Access UCL Research: Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis https://t.co/dfu2shNBcK
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis. https://t.co/CTfj0asVmU
RT @AETSA_: #Cochrane_Publica #Rev_Sist Eficacia y seguridad tratamientos #hepatitis_B aguda https://t.co/nhcwaIK6Tx @sefh_ @sepdigestiva @…
RT @AETSA_: #Cochrane_Publica #Rev_Sist Eficacia y seguridad tratamientos #hepatitis_B aguda https://t.co/nhcwaIK6Tx @sefh_ @sepdigestiva @…
RT @AETSA_: #Cochrane_Publica #Rev_Sist Eficacia y seguridad tratamientos #hepatitis_B aguda https://t.co/nhcwaIK6Tx @sefh_ @sepdigestiva @…
RT @tufarmaceuTIC: @CochraneLibrary Metanalisis 2017 tto farmacológico #HepatitisB Aguda #VHB https://t.co/6j3W0hvocA Controversia Lamivud…
@CochraneLibrary Metanalisis 2017 tto farmacológico #HepatitisB Aguda #VHB https://t.co/6j3W0hvocA Controversia Lamivud vs placebo vs entec
RT @AETSA_: #Cochrane_Publica #Rev_Sist Eficacia y seguridad tratamientos #hepatitis_B aguda https://t.co/nhcwaIK6Tx @sefh_ @sepdigestiva @…
#Cochrane_Publica #Rev_Sist Eficacia y seguridad tratamientos #hepatitis_B aguda https://t.co/nhcwaIK6Tx @sefh_ @sepdigestiva @safh_info
RT @GPI_AEPap: Top story: Medical treatment of acute hepatitis B virus infection | Cochrane https://t.co/IcYKIR2qYR, see more https://t.co/…
RT @cochrane_nz: Medical treatment of acute #hepatitisB virus infection. Latest Cochrane Evidence. https://t.co/g0LvvfeK0H @HepFoundationNZ…
RT @cochrane_nz: Medical treatment of acute #hepatitisB virus infection. Latest Cochrane Evidence. https://t.co/g0LvvfeK0H @HepFoundationNZ…
Top story: Medical treatment of acute hepatitis B virus infection | Cochrane https://t.co/IcYKIR2qYR, see more https://t.co/WsKAM2WUzT
Top story: Medical treatment of acute hepatitis B virus infection | Cochrane https://t.co/IcYKIR2qYR, see more https://t.co/k518MyAMfj
RT @rincondesisifo: (Cochrane) La evidencia actual no respalda el tto farmacológico de la infección aguda por VHB https://t.co/dHuLvIzjF4
RT @rincondesisifo: (Cochrane) La evidencia actual no respalda el tto farmacológico de la infección aguda por VHB https://t.co/dHuLvIzjF4
Medical treatment of acute hepatitis B virus infection https://t.co/FtyN3LZe9p
Medical treatment of acute #hepatitisB virus infection. Latest Cochrane Evidence. https://t.co/g0LvvfeK0H @HepFoundationNZ https://t.co/yY6FtHfQ9E
Medical treatment of acute #hepatitisB virus infection. @CochraneLibrary #hepB #HBV https://t.co/JU1cpPMbun
Medical treatment of acute hepatitis B virus infection https://t.co/HIObrSZPX2 #hepatitisB
(Cochrane) La evidencia actual no respalda el tto farmacológico de la infección aguda por VHB https://t.co/dHuLvIzjF4